Freedom Capital Markets Maintains Hold on AtriCure, Maintains $57 Price Target

Benzinga · 1d ago
Freedom Capital Markets analyst Keith Hinton maintains AtriCure (NASDAQ:ATRC) with a Hold and maintains $57 price target.